Jost Fischer - 19 May 2025 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role: Director
Signature: /s/ Alexander Wilson as attorney-in-fact for Jost Fischer
Issuer symbol: AEON
Transactions as of: 19 May 2025
Net transactions value: +$55,300
Form type: 4
Filing time: 21 May 2025, 16:50:20 UTC
Previous filing: 04 Sep 2024
Next filing: 23 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
FISCHER JOST	Director	5 PARK PLAZA, SUITE 1750, IRVINE	/s/ Alexander Wilson as attorney-in-fact for Jost Fischer	21 May 2025	0001366841

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AEON	Class A Common Stock	Purchase	$24,940	+50,000	+52%	$0.4988	146,785	19 May 2025	Direct	F1
transaction	AEON	Class A Common Stock	Purchase	$30,360	+60,000	+41%	$0.5060	206,785	20 May 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades in prices ranging from $0.4844 to $0.51, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
F2	This transaction was executed in multiple trades in prices ranging from $0.50 to $0.5132, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Content

This transaction was executed in multiple trades in prices ranging from $0.4844 to $0.51, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

This transaction was executed in multiple trades in prices ranging from $0.50 to $0.5132, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.